ŞENOCAK, A. Et Al. 2022. Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.36, no.3 .

ŞENOCAK, A., Tas, N. A., Taslimi, P., TÜZÜN, B., AYDIN, A., & KARADAĞ, A., (2022). Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.36, no.3.

ŞENOCAK, AYŞEGÜL Et Al. "Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies," JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.36, no.3, 2022

ŞENOCAK, AYŞEGÜL Et Al. "Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.36, no.3, 2022

ŞENOCAK, A. Et Al. (2022) . "Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.36, no.3.

@article{article, author={AYŞEGÜL ŞENOCAK Et Al. }, title={Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies}, journal={JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY}, year=2022}